- Mar 6, 2023
Voximetry Launches Clinical Operations Support to accelerate adoption of Torch® Dose Assessment and Dosimetry Services
Who We Are
A Leader in GPU-Accelerated Complex Algorithm Implementation
Technology that Raises the Standard of Care
Voximetry is a Healthtech software company committed to advancing dosimetry-guided Radiopharmaceutical Therapy (DG-RPT). With Torch™, we aim to improve patient outcomes by moving beyond population based models and making it simpler for clinicians to develop patient-specific RPT treatment options.
Executive Leadership
Sue Wallace, PhD
Chief Executive Officer
Board Director
Sue has over 30 years managing medical device businesses in the fields of nuclear medicine and radiation oncology, including high profile executive roles at GE, Cardinal Health, Philips, and Accuray. She holds a Doctorate in radiopharmaceutical chemistry and is a Six Sigma Master Black Belt.
Joseph Grudzinski, PhD
Chief Innovation Officer
Board Director
Co-Founder
Joe has over 15 years of experience developing radiopharmaceuticals at multiple drug companies and radiation dosimetry algorithms at Philips Radiation Oncology Systems. Joe remains active as Senior Scientist in the Department of Radiology at the University of Wisconsin-Madison.
Abhi Chakrabarti, PhD
Chief Operating Officer
Abhi has over 25 years driving Healthtech software product design and commercial growth of treatment planning applications, including executive roles at Philips Healthcare and Elekta. He holds a Doctorate in Electrical & Electronic Engineering and a PhD in Numerical Modelling of Semiconductors.
Paul Wickre
Chief Technology Officer
Board Director
Co-Founder
Paul has over 20 years commercializing software including radiation treatment planning and quality assurance at Philips Radiation Oncology Systems and Standard Imaging. Mr. Wickre has been developing radiation treatment planning software for the past 13 years under strict FDA regulatory guidelines.
Bryan Bednarz, PhD
Chief Science Officer
Board Director
Co-Founder
Bryan has over 15 years of experience in radiation transport methods, dosimetry and medical device development. Bryan is a tenured Associate Professor in the Department of Medical Physics at the University of Wisconsin-Madison.
Michael Lafont, MMSc, DABR
Vice President – Sales
Michael has over 25 years leading clinical care and commercial sales teams, including executive roles at Varian Medical Systems and McKesson Specialty Health. Michael is a Licensed, Board Certified Radiation Oncology Physicist. He holds degrees in Mathematics and Physics from the University of Akron, a Master’s degree from Emory University, and further post graduate studies from Georgia State and the University of Chicago Booth School of Business.
Patrick Morse
Vice President – Global Clinical Operations
Patrick has over 12 years of experience in industry and academic institutions in Research, Clinical Operations, Medical Affairs, Sales and Marketing. He has held leadership positions in ZAP Surgical, Accuray, Elekta, University of Virginia and Northwestern University. He holds a BS in Molecular and Cellular Biology and an Executive MBA.
Advanced Imaging and Dosimetry Leadership
Chuck Stearns, PhD
Senior Advanced Development Engineer
Chuck has over 30 years of imaging systems design, data processing, and image reconstruction experience at GE Healthcare, including 5 years as Chief PET/CT Engineer. He holds a doctorate in Medical Engineering from MIT.
Hari Gopalakrishnan
Senior Software Development Engineer
Hari has over 18 years of experience developing software for commercial and research purposes. For the last 10 years, he has worked in the FDA-regulated medical device industry developing efficient and effective treatment planning algorithms for external beam radiation therapy.
Koua Yang
Senior Software Development Engineer
Koua has nearly 20 years of experience developing commercial software at Philips and GE Healthcare. He is a highly skilled software engineer with expertise in image and medical data processing, including a focus on radiotherapy DICOM standards.
Key Advisors
Dr. Richard L Wahl
Chair of Scientific & Clinical Advisory Board
Dr. Wahl was among the first to precisely target internal radiation therapy to cancers. He has a successful track record of innovation from the pre-clinical stage to the clinical environment. His significant translational success includes 20 patents, 2 FDA approved cancer treatments and at least 3 FDA approved devices. Dr. Wahl is Director of the Mallinckrodt Institute of Radiology at Washington University School of Medicine, Head of the Department of Radiology, and a Professor of Radiation Oncology
Andreas Schulte
International Business Development
Andreas has extensive experience in global business development including driving significant commercial growth in radiation oncology. Today he is specializing in market entry strategies supporting radiation oncology start-ups and clinical operators.
NEWS & WEBINARS
- Feb 21, 2023
Voximetry Announces Experienced Commercial Leadership Hired for Launch of Torch® Dose Assessment in the U.S.
- Feb 3, 2023
Voximetry positions for growth with hiring of Chief Operating Officer Dr. Abhi Chakrabarti
- Dec 8, 2022
Pluvicto Demonstrates Clinical Benefit in Prostate Cancer Before Chemo